105008-7 |
MDS v3.0 - RAI v1.19.1 - Nursing home and Swing bed tracking (NT ST) item set |
- |
^Patient |
RptPeriod |
- |
CMS Assessment |
|
ACTIVE |
MDS v3.0 - RAI v1.19.1 - Nursing home and Swing bed tracking (NT ST) item set during assessment period [CMS Assessment] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
105008-7 |
|
CMS Assessment |
|
|
Order |
|
|
|
0 |
|
|
|
|
N |
|
Centers for Medicare and Medicaid Assessment; MDS v3.0 - RAI v1.19.1 - NT & ST; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey |
2.78 |
2.78 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
105009-5 |
Chloride.reabsorbed by renal tubules/Chloride.total filtered |
MFr |
Urine+Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Chloride.reabsorbed by renal tubules/Chloride.total filtered in Urine and Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
The renal tubular reabsorption of chloride is useful for evaluating patients with hypochloremia and may be calculated as follows: Urine flow = volume in mL/ time in minutes = mL/min.; Glomerular Filtration Rate (GFR) = urine* x urine flow/plasma*; (* = creatinine or iothalamate); Clearance of Chloride (CCl) = urine Cl x urine flow/serum Cl; Free water clearance CH2O) = urine flow-(urine osmolality x urine flow/plasma osmolality); TRCl = (1- CCl ) x 100 |
|
|
|
CHEM |
|
105009-5 |
|
|
|
|
Both |
|
|
|
0 |
Cl.reab ren tub/Cl.tot fil MFr Ur+SerPl |
|
|
|
N |
|
Chemistry; Cl; Cl-; Cl reab/Cl. tot filt; Cl.reab ren tub; Cl.tot fil; Kidney; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl; UA; UR; Ur+SerPl; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
10501-5 |
Lutropin |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mIU/mL |
|
|
|
|
|
|
CHEM |
|
10501-5 |
|
|
|
|
Both |
|
|
|
0 |
LH SerPl-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Chemistry; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1.0i |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
127 |
105010-3 |
Folate receptor alpha |
Imp |
Tiss |
Pt |
Nar |
Immune stain |
|
ACTIVE |
Folate receptor alpha [Interpretation] in Tissue by Immune stain Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
105010-3 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Folate alpha Tiss ImStn-Imp |
|
|
|
N |
|
Alfa; Folat; Folate alpha; Folic acid; IHC; Imm; Immunohistochemical stain; Immunostain; Impression; Impression/interpretation of study; Impressions; ImStn; Imun; Imune; Interp; Interpretation; Narrative; Pathology; Point in time; Pteroylglutamate; Pteroylglutamic acid; Random; Rec; Recept; Receptors; Recp; Recptr; Report; St; Stains; Stn; Tissue; Tissue, unspecified; Vit M; Vitamin M |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105011-1 |
Claudin 18 |
Imp |
Tiss |
Pt |
Nar |
Immune stain |
|
ACTIVE |
Claudin 18 [Interpretation] in Tissue by Immune stain Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
105011-1 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Claudin 18 Tiss ImStn-Imp |
|
|
|
N |
|
IHC; Imm; Immunohistochemical stain; Immunostain; Impression; Impression/interpretation of study; Impressions; ImStn; Imun; Imune; Interp; Interpretation; Narrative; Pathology; Point in time; Random; Report; St; Stains; Stn; Tissue; Tissue, unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105012-9 |
Fungal ITS region |
PrThr |
Specimen |
Pt |
Ord |
Sequencing |
|
ACTIVE |
Fungal ITS region [Presence] in Specimen by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
105012-9 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
Fungal ITS region Spec Ql Seq |
|
|
|
N |
|
high-throughput sequencing; HTS; Microbiology; Next generation sequencing; NGS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105013-7 |
Bacterial carbapenem resistance blaGES-11 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial carbapenem resistance blaGES-11 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105013-7 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaGES-11 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105014-5 |
Bacterial Carbapenem resistance blaGES-5 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaGES-5 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105014-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaGES-5 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105015-2 |
Bacterial Carbapenem resistance blaGIM-1 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaGIM-1 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105015-2 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaGIM-1 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; i; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105016-0 |
Bacterial Carbapenem resistance blaKPC-18 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaKPC-18 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105016-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaKPC-18 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105017-8 |
Bacterial Carbapenem resistance blaKPC-2 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaKPC-2 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105017-8 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaKPC-2 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; II; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105018-6 |
Bacterial Carbapenem resistance blaKPC-3 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaKPC-3 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105018-6 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaKPC-3 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; III; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105019-4 |
Bacterial Carbapenem resistance blaNDM-1 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaNDM-1 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105019-4 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaNDM-1 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; i; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10502-3 |
Lutropin Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Lutropin Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10502-3 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
LH Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; ICSH; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ordinal; Ovulation test; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.73 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
105020-2 |
Bacterial Carbapenem resistance blaNDM-19 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaNDM-19 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105020-2 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaNDM-19 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105021-0 |
Bacterial Carbapenem resistance blaNDM-4 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaNDM-4 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105021-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaNDM-4 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105022-8 |
Bacterial Carbapenem resistance blaNDM-5 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaNDM-5 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105022-8 |
|
Molgen |
|
|
Order |
|
|
|
0 |
blaNDM-5 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105023-6 |
Bacterial Carbapenem resistance blaNDM-7 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaNDM-7 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105023-6 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaNDM-7 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105024-4 |
Bacterial Carbapenem resistance blaNDM-9 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaNDM-9 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105024-4 |
|
Molgen |
|
|
Order |
|
|
|
0 |
blaNDM-9 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105025-1 |
Bacterial Carbapenem resistance blaOXA 181 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaOXA 181 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105025-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaOXA 181 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105026-9 |
Bacterial Carbapenem resistance blaOXA-162 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaOXA-162 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105026-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaOXA-162 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105027-7 |
Bacterial Carbapenem resistance blaOXA-23 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaOXA-23 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105027-7 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaOXA-23 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105028-5 |
Bacterial Carbapenem resistance blaOXA-232 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaOXA-232 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105028-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaOXA-232 Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
105029-3 |
Bacterial Carbapenem resistance blaOXA24/40 gene |
PrThr |
Isolate/Specimen |
Pt |
Ord |
Molgen |
|
ACTIVE |
Bacterial Carbapenem resistance blaOXA24/40 gene [Presence] by Molecular method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
105029-3 |
|
Molgen |
|
|
Both |
|
|
|
0 |
blaOXA24/40 gene Islt/Spm Ql |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10503-1 |
Lysozyme Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Lysozyme Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10503-1 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Lysozyme Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; k208; Lysozymes; Muramidase; N-Acetylmuramide Glycanhydrolase; nGal d 4 Lysozyme, Egg; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Rk208; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.73 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |